BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24925215)

  • 1. Enhancement of mitochondrial ATP production by the Escherichia coli cytotoxic necrotizing factor 1.
    Travaglione S; Loizzo S; Rizza T; Del Brocco A; Ballan G; Guidotti M; Vona R; Di Nottia M; Torraco A; Carrozzo R; Fiorentini C; Fabbri A
    FEBS J; 2014 Aug; 281(15):3473-88. PubMed ID: 24925215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and cytoprotective activity of the small GTPase RhoB induced by the Escherichia coli cytotoxic necrotizing factor 1.
    Huelsenbeck SC; Roggenkamp D; May M; Huelsenbeck J; Brakebusch C; Rottner K; Ladwein M; Just I; Fritz G; Schmidt G; Genth H
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1767-75. PubMed ID: 23732113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkappaB kinase pathway: role of nuclear factor-kappaB and Bcl-2.
    Miraglia AG; Travaglione S; Meschini S; Falzano L; Matarrese P; Quaranta MG; Viora M; Fiorentini C; Fabbri A
    Mol Biol Cell; 2007 Jul; 18(7):2735-44. PubMed ID: 17507655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNF1 Enhances Brain Energy Content and Counteracts Spontaneous Epileptiform Phenomena in Aged DBA/2J Mice.
    Travaglione S; Ballan G; Fortuna A; Ferri A; Guidotti M; Campana G; Fiorentini C; Loizzo S
    PLoS One; 2015; 10(10):e0140495. PubMed ID: 26457896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors.
    Pavone F; Luvisetto S; Marinelli S; Straface E; Fabbri A; Falzano L; Fiorentini C; Malorni W
    Pain; 2009 Sep; 145(1-2):219-29. PubMed ID: 19608345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study.
    Fabbri A; Travaglione S; Maroccia Z; Guidotti M; Pierri CL; Primiano G; Servidei S; Loizzo S; Fiorentini C
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic necrotizing factor 1 hinders skeletal muscle differentiation in vitro by perturbing the activation/deactivation balance of Rho GTPases.
    Travaglione S; Messina G; Fabbri A; Falzano L; Giammarioli AM; Grossi M; Rufini S; Fiorentini C
    Cell Death Differ; 2005 Jan; 12(1):78-86. PubMed ID: 15514676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxin-induced activation of Rho GTP-binding protein increases Bcl-2 expression and influences mitochondrial homeostasis.
    Fiorentini C; Matarrese P; Straface E; Falzano L; Fabbri A; Donelli G; Cossarizza A; Boquet P; Malorni W
    Exp Cell Res; 1998 Jul; 242(1):341-50. PubMed ID: 9665831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome.
    De Filippis B; Valenti D; Chiodi V; Ferrante A; de Bari L; Fiorentini C; Domenici MR; Ricceri L; Vacca RA; Fabbri A; Laviola G
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):889-901. PubMed ID: 25890884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties.
    Munro P; Flatau G; Anjuère F; Hofman V; Czerkinsky C; Lemichez E
    Vaccine; 2005 Apr; 23(20):2551-6. PubMed ID: 15780436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-to-cell propagation of the bacterial toxin CNF1 via extracellular vesicles: potential impact on the therapeutic use of the toxin.
    Fabbri A; Cori S; Zanetti C; Guidotti M; Sargiacomo M; Loizzo S; Fiorentini C
    Toxins (Basel); 2015 Nov; 7(11):4610-21. PubMed ID: 26556375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
    Gingras D; Lamy S; Béliveau R
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hinderance of apoptosis and phagocytic behaviour induced by Escherichia coli cytotoxic necrotizing factor 1: two related activities in epithelial cells.
    Fiorentini C; Fabbri A; Matarrese P; Falzano L; Boquet P; Malorni W
    Biochem Biophys Res Commun; 1997 Dec; 241(2):341-6. PubMed ID: 9425273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bacterial Toxin CNF1 Protects Human Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine-Induced Cell Damage: The Hypothesis of CNF1-Promoted Autophagy as an Antioxidant Strategy.
    Travaglione S; Loizzo S; Vona R; Ballan G; Rivabene R; Giordani D; Guidotti M; Dupuis ML; Maroccia Z; Baiula M; Rimondini R; Campana G; Fiorentini C
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration.
    Palorini R; De Rasmo D; Gaviraghi M; Sala Danna L; Signorile A; Cirulli C; Chiaradonna F; Alberghina L; Papa S
    Oncogene; 2013 Jan; 32(3):352-62. PubMed ID: 22410778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli cytotoxic necrotizing factor 1 inhibits intestinal epithelial wound healing in vitro after mechanical injury.
    Brest P; Turchi L; Le'Negrate G; Berto F; Moreilhon C; Mari B; Ponzio G; Hofman P
    Infect Immun; 2004 Oct; 72(10):5733-40. PubMed ID: 15385472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response.
    Munro P; Flatau G; Doye A; Boyer L; Oregioni O; Mege JL; Landraud L; Lemichez E
    J Biol Chem; 2004 Aug; 279(34):35849-57. PubMed ID: 15152002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's disease.
    Loizzo S; Rimondini R; Travaglione S; Fabbri A; Guidotti M; Ferri A; Campana G; Fiorentini C
    PLoS One; 2013; 8(5):e65898. PubMed ID: 23738020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of the Rho GTPase modulator CNF1 in a model of Parkinson's disease.
    Musilli M; Ciotti MT; Pieri M; Martino A; Borrelli S; Dinallo V; Diana G
    Neuropharmacology; 2016 Oct; 109():357-365. PubMed ID: 27350290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine.
    Flatau G; Lemichez E; Gauthier M; Chardin P; Paris S; Fiorentini C; Boquet P
    Nature; 1997 Jun; 387(6634):729-33. PubMed ID: 9192901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.